晉西車軸(600495.SH):上半年預盈875萬元-1050萬元 同比扭虧
格隆匯7月11日丨晉西車軸(600495.SH)公佈,公司預計2022年半年度實現歸屬於上市公司股東的淨利潤為875萬元到1050萬元,與上年同期相比,將實現扭虧為盈。預計2022年上半年實現歸屬於母公司所有者的扣除非經常性損益後的淨利潤為-1325萬元到-1150萬元。
2022年上半年,鐵路產品市場需求持續改善,公司主營產品鐵路車輛、車軸、搖枕側架產銷同比大幅增長,且毛利率同比有所提升。本期公司非經常性收益同比增加約650萬元,主要原因是計入當期損益的政府補助、現金管理產品收益較上年同期增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.